CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZNCF

Dapagliflozin propanediol (FORXIGA™/FARXIGA™1)

Phase 3
ASTRAZENECA PLC (AZNCF)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
AZNCFPhase 3

Dapagliflozin propanediol (FORXIGA™/FARXIGA™1) Phase 3 Est. Readout

Dapagliflozin propanediol (FORXIGA™/FARXIGA™1)
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in AMI

View Full Landscape
Drug Information

Target Indication

AMI

Clinical Trial

NCT05764057

Last updated: 9/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.